Skip to main content

Table 2 Lymphocytes subsets (cells/μL) at the beginning (V1), after 2 (V2) and 6 weeks (V3) of intervention

From: Evaluation of Lactobacillus coryniformis CECT5711 strain as a coadjuvant in a vaccination process: a randomised clinical trial in healthy adults

 

V1

V2

V3

 

Mean

SD

Mean

SD

Mean

SD

P #

CD3+ Lymphocytes

 Control

1851

589

1817

626

1865

507

NS

 PRO2

1660

522

1695

496

1861

558

NS

 PRO1

1812

494

1802

422

1876

401

NS

CD8+ Lymphocytes

 Control

611

229

608

250

605

191

NS

 PRO2

512

217

519

236

576

239

NS

 PRO1

543

193

536

194

553

171

NS

CD4+ Lymphocytes

 Control

1073

382

1034

420

1104

387

NS

 PRO2

992

345

1007

315

1132

395

NS

 PRO1

1111

323

1099

280

1160

278

NS

CD19+ Lymphocytes

 Control

248

102

248

98

250

123

NS

 PRO2

234

101

251

89

261

105

NS

 PRO1

273

104

289

120

285

114

NS

CD3-CD16 + CD56+ Cells

 Control

299

154

272

164

278

169

NS

 PRO2

275

138

281

144

236

105

NS

 PRO1

328

196

311

172

305

165

NS

CD8 + CD45RA+ Lymphocytes

 Control

336

158

326

170

337

138

NS

 PRO2

282

158

290

137

327

159

NS

 PRO1

304

136

290

132

309

309

NS

CD3 + CD8 + CD45RO+ Lymphocytes

 Control

291

147

269

113

274

109

NS

 PRO2

232

108

235

126

211

133

NS

 PRO1

263

110

251

115

256

104

NS

CD4 + CD45RA+ Lymphocytes

 Control

443

245

413

242

451

246

NS

 PRO2

405

218

405

204

454

247

NS

 PRO1

483

224

452

174

513

205

NS

CD3 + CD4 + CD45RO+ Lymphocytes

 Control

581

195

562

193

630

217

NS

 PRO2

551 a

213

594 ab

215

660 b

223

0.032

 PRO1

565

221

583

196

616

200

NS

  1. Data are expressed as mean ± SD. #Differences among visits within each group, also highlighted in bold. Repeated measures ANOVA with “visit” as fixed factor and “sex” as randomized factor (P < 0.05). Different superscripts mean significant differences between visits; Bonferroni test (P < 0.05)